Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
3.20    -0.20 (-5.88%)
Bid:
3.20
Ask:
3.44
Spread: 0.24 (7.50%)
Market Cap: £5.84m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

PrimaryBid.com Offer

15 Jul 2020 17:20

RNS Number : 1337T
Nanoco Group PLC
15 July 2020
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021)

 

15 July 2020

 

Nanoco Group plc

("Nanoco" or the "Company") (LON:NANO)

PrimaryBid.com Offer

 

Nanoco Group plc (LON:NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform, is pleased to announce an offer for subscription via PrimaryBid (the "PrimaryBid Offer") of new ordinary shares of 10p each in the Company ("New Ordinary Shares") at an issue price of 17.5 pence per New Ordinary Share (the "Issue Price"), being a discount of 2.8% per cent to the closing mid-price on 15 July 2020 as announced earlier on 15 July 2020 .

The PrimaryBid Offer is conditional on the new Ordinary Shares to be issued pursuant to the PrimaryBid Offer being admitted to listing on the Official List by the Financial Conduct Authority and to trading by the London Stock Exchange on its main market for listed securities ("Admission"). Admission is expected to be take place at 8.00 a.m. on 20 July 2020.

The net proceeds of the Fundraising will be used to extend the Company's cash runway at least to the end of calendar year 2021 while supporting its core IP assets and its business operations during the ongoing lawsuit against Samsung.

The Company's largest shareholder, Lombard Odier, has undertaken to subscribe for £2.14m of New Ordinary Shares on the same terms as those set out above, which subscription shall be subject to claw back depending on the amount of the other aggregate applications received from other investors under the PrimaryBid Offer. Lombard Odier will receive, conditional upon Admission (as defined below), a subscription commission equal to 3.0 per cent of the amount it subscribes . In the event that Admission does not occur, Lombard Odier will not receive any commission payment. .

Certain directors of the Company and/or persons closely associated with them have given written undertakings to the Company to subscribe for PrimaryBid Shares at the Issue Price with a total value of £61,000.

PrimaryBid Offer

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the PrimaryBid Offer by applying exclusively through the www.PrimaryBid.com platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The PrimaryBid Offer, via the PrimaryBid.com platform, will be open to individual and institutional investors immediately following this announcement and will close at 9:00 p.m. on 15 July 2020. The PrimaryBid Offer may close early if it is oversubscribed.

Subscriptions under the PrimaryBid Offer will be considered by the Company on a "first come, first served" basis, subject to conditions (which are available to view on PrimaryBid.com).

The Company in consultation with PrimaryBid reserves the right to scale back any order at its discretion. The Company and PrimaryBid reserve the right to reject any application for subscription under the Offer without giving any reason for such rejection. It is not intended that the Director orders be subject to scale back.

No commission is charged to investors on applications to participate in the PrimaryBid Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

For further information on PrimaryBid.com or the procedure for applications under the PrimaryBid Offer, visit www.PrimaryBid.com or call PrimaryBid.com on +44 20 3026 4750. 

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing Ordinary Shares.

Nanoco Group PLC

Michael Edelman, CEO

Brian Tenner, COO & CFO

Caroline Watson, Investor Relations Manager

 

+44 (0) 161 603 7900

PrimaryBid Limited

James Deal / Kieran D'Silva

 

+ 44 (0) 203 026 4750

Further Details of the Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the Offer. The Company is therefore making the Offer available exclusively through PrimaryBid.com.

The Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of a prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

There is a minimum subscription of £100 per investor under the terms of the Offer which is open to existing shareholders and other investors subscribing via PrimaryBid.com. This allocation will be filled on a "first come first served" basis.

For further details please refer to the PrimaryBid.com website at www.PrimaryBid.com. The terms and conditions on which the Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt. 

 

 

END

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OFFBLGDRXBBDGGU
Date   Source Headline
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company
20th Jul 202012:35 pmRNSHolding(s) in Company
16th Jul 20202:15 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSResult of Fund Raise
15th Jul 20205:20 pmRNSPrimaryBid.com Offer
15th Jul 20205:17 pmRNSTrading Update and Proposed Fundraising
14th Jul 20209:55 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSLitigation Funding Agreement
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jun 202010:06 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSBlocklisting Six-Monthly Return
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:35 pmRNSPrice Monitoring Extension
28th May 20207:00 amRNSQuantum Dot Material Supply Agreement
30th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
30th Apr 20207:00 amRNSInterim Results
30th Apr 20207:00 amRNSTermination of Formal Sale Process
29th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
28th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
27th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
24th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
23rd Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
22nd Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
21st Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
20th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
17th Apr 20204:41 pmRNSSecond Price Monitoring Extn
17th Apr 20204:36 pmRNSPrice Monitoring Extension
17th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
16th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
15th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
14th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
9th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
8th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
7th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
6th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
3rd Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
3rd Apr 202011:35 amRNSNanoco Group
2nd Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:37 pmRNSPrice Monitoring Extension
1st Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
31st Mar 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
31st Mar 202011:07 amRNSNanoco Group
30th Mar 20201:05 pmRNSCovid-19 Update
30th Mar 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
27th Mar 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
26th Mar 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
25th Mar 20205:05 pmRNSLicence Partner Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.